TRADESHOW reCAP
WEBINAR reCAP
A lot of great takeaways from this years’ Venturepark Summit, especially from the conversation with Ted Fleming, Suzie Yorke, and Arlene Dickinson on the realities of building and scaling a CPG brand.
From our perspective, regulatory strategy is part of that same growth story. It is not about slowing down innovation, it is all about helping brands understand how today’s decisions may shape where they are able to go next.
We recently welcomed the Fraser Valley Organic Producers Association (FVOPA) for a guest webinar on the organic certification process in Canada.
Watch the latest webinar on demand now for an overview of organic certification framework, Organic System Plan requirements, traceability expectations, record maintenance, usage of the Canada Organic Logo, and more!
FOOD UPDATE
Sports
Electrolytes
NHP UPDATE
FPS Updates,
Melatonin Update
INDUSTRY INSIGHT
Health Canada GMP Trends & Compliance
Health Canada has reclassified sports electrolyte products marketed for hydration during and after exercise and for electrolyte replacement as foods, with a transition deadline of December 31, 2027. Companies must align with the FDR, including supplemented food requirements, to
remain compliant.
Effective June, Health Canada will classify melatonin products sold for sleep-related use in children and adolescents under 18 years of age as prescription drugs under the Food and Drug Regulations. The amendment also reflects heightened regulatory sensitivity around products intended for children
and adolescents.
SNI attended discussions on recent Good Manufacturing Practices (GMP) where Health Canada provided insight into inspection observations across the regulated industry, highlighting common compliance challenges identified through domestic and foreign inspections conducted under Division 2 of
the FDR.
EVOLVING NATURAL HEALTH PRODUCT REGULATORY FRAMEWORK
Preparing for Health Canada Discussions and the Future of NHP Regulations
> WHAT THIS MEANS FOR DEVELOPMENT, IMPORTATION AND MARKETING
While straightforward market-entry pathways for medical devices in Canada can often be mapped internally, certain device and commercialization structures benefit from a formal regulatory pathway assessment early in development.
Health Canada is proposing a streamlined authorization pathway for certain low-risk products like sunscreens, acne treatments, anti-dandruff products, antiperspirants, therapeutic oral care products, and medicated skin care.
Who’s Attending?
CHFA NOW 2026
Toronto – Sept. 25, 2026
We will once again be joining thousands of industry professionals at CHFA NOW Toronto — Canada’s premier trade show for natural, organic and wellness.
DISCOVER MORE BLOG CONTENT
